Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06168812
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2023-12-05
Brief Title:
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Sulfonylurea Safety and Effectiveness SUSS for Patients With Hyperglycemia and Pancreatic Ductal Adenocarcinoma A Pragmatic Clinical Trial and Accompanying Retrospective Revie
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out how effective and safe glipizide is for lowering blood sugar in people with pancreatic cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None